Market Valuation: Exicure Corp (XCUR)

Public company logo of Exicure Inc. (XCUR)

Exicure, Inc. (XCUR) is currently restoring its business reputation, striving to regain investor confidence by stabilizing its image. Meanwhile, the business remains vulnerable due to geopolitical risks and the complexity of genetic data exchange. This chart of the asset's value on GURU.Markets, where the market capitalization stands at 0.01, complements the profile of the company, which relies on outsourcing production and testing to maintain the mobility of its scientific team.

XCUR Exicure: Market Value in the range 07/04/2022 - 11/12/2026
Original product of exicuretx.com

Fundamental asset selection is based on objective financial reporting data. This indicator measures the aggregate value of all shares, determined by market demand and supply. For Exicure, Inc. (XCUR), this metric reflects investment resilience against Asian supply chain disruptions and patent risks. Large-Cap status minimizes the probability of default, although it constrains growth rates. The dynamics of these processes are reflected in the company's total market capitalization.

Competitor analysis

Market Capitalization TEM (Tempus)|QGEN - Market Valuation|IONS: Market Valuation|RGEN - Market Capitalization|Avidity Biosciences (RNA) - Market Value|crisprtx.com - Market Value|WGS (GeneDx) - Market Capitalization|Market Capitalization RARE (Ultragenyx Pharmaceutical Inc.)|Market Value Beam Therapeutics Corp (BEAM)|Sarepta Corp - Market Capitalization|Market Capitalization TWST (Twist Bioscience)|Market Capitalization 10xgenomics.com TXG|Intellia Therapeutics, Inc. - Market Capitalization|Market Value Stoke Therapeutics Inc|BLFS (BioLife Corp) - Market Valuation|Market Capitalization WVE|MAZE (Maze Therapeutics Inc) - Market Capitalization|sionnatx.com (SION) - Market Capitalization|Market Capitalization PRME|Market Valuation Taysha Gene Therapies Inc TSHA|uniQure Corp - Market Valuation|Market Capitalization MeiraGTx Corp MGTX|RGNX - Market Value|Market Value SLDB (solidbio.com)|OCGN: Market Capitalization|Market Value Pacific Biosciences of California, Inc. (PACB)|Market Valuation BNTC|DSGN: Market Value|Market Capitalization RCKT|Market Capitalization 4dmoleculartherapeutics.com|Market Value Lexeo Therapeutics, Inc. LXEO|KRRO: Market Capitalization|Editas - Market Capitalization|Silence Therapeutics Corp (SLN) - Market Valuation|PRQR (proqr.com) - Market Valuation|CDXS - Market Capitalization|Market Valuation SGMO|Market Capitalization NAUT (Nautilus Biotechnology Inc)|Market Capitalization MGX|Market Valuation precisionbiosciences.com DTIL|Generation Bio - Market Valuation|Market Capitalization boundlessbio.com BOLD|IMNN - Market Value|Market Value PHIO (Phio Pharmaceuticals)|MBIO: Market Capitalization|Market Capitalization RNAZ|Market Value Bionano Genomics Inc.|Market Capitalization APDN (adnas.com)|Market Capitalization BLUE|Market Capitalization immunoprecise.com (IPA)|Market Capitalization OMGA (Omega)|Singular Genomics Corp (OMIC) - Market Value|RGLS: Market Valuation|SYRS (syros.com) - Market Capitalization|TBIO: Market Capitalization|TCON - Market Capitalization|UBX (Unity Bio) - Market Capitalization